The latest news and updates about Post-Finasteride Syndrome Mitch Sabine 8/6/23 Mitch Sabine 8/6/23 New paper from Dr Michael Irwig demonstrates dire clinical reality facing patients Read More Mitch Sabine 7/30/23 Mitch Sabine 7/30/23 FDA Patient Listening Session Read More Mitch Sabine 7/9/23 Mitch Sabine 7/9/23 2023 updates from PFS Network Read More Mitch Sabine 9/24/22 Mitch Sabine 9/24/22 Israeli victims of finasteride speak out: “I woke up in a nightmare” Read More Mitch Sabine 3/31/22 Mitch Sabine 3/31/22 Quarterly updates and insights from PFS Network Read More Mitch Sabine 3/1/22 Mitch Sabine 3/1/22 A note on proposed etiologies about Post-Finasteride Syndrome Read More Mitch Sabine 2/22/22 Mitch Sabine 2/22/22 How to speak to your doctor about Post-Finasteride Syndrome, and why it’s important Read More Mitch Sabine 2/16/22 Mitch Sabine 2/16/22 Post-Finasteride Syndrome: A devastating disease with a trail of suicides Read More Mitch Sabine 2/3/22 Mitch Sabine 2/3/22 The most frequently asked questions by new PFS patients Read More Mitch Sabine 1/13/22 Mitch Sabine 1/13/22 The 6 most commonly asked questions about Post-Finasteride Syndrome Read More Newer Posts Older Posts
Mitch Sabine 8/6/23 Mitch Sabine 8/6/23 New paper from Dr Michael Irwig demonstrates dire clinical reality facing patients Read More
Mitch Sabine 9/24/22 Mitch Sabine 9/24/22 Israeli victims of finasteride speak out: “I woke up in a nightmare” Read More
Mitch Sabine 3/1/22 Mitch Sabine 3/1/22 A note on proposed etiologies about Post-Finasteride Syndrome Read More
Mitch Sabine 2/22/22 Mitch Sabine 2/22/22 How to speak to your doctor about Post-Finasteride Syndrome, and why it’s important Read More
Mitch Sabine 2/16/22 Mitch Sabine 2/16/22 Post-Finasteride Syndrome: A devastating disease with a trail of suicides Read More
Mitch Sabine 2/3/22 Mitch Sabine 2/3/22 The most frequently asked questions by new PFS patients Read More
Mitch Sabine 1/13/22 Mitch Sabine 1/13/22 The 6 most commonly asked questions about Post-Finasteride Syndrome Read More
